Pharmaceutical companies are no strangers to digital technology, either in the science that creates their products or in the business of bringing them to the people who prescribe them. As the use of digital-first experiences intensifies and the pharmaceutical industry is forced to evolve, companies will need to lean on their data and technologies in their engagement efforts to deliver elevated human experiences.

Public safety is the world’s singular goal as mandatory quarantines, shelter-in-place orders, travel restrictions, and mandatory work-from-home policies go into effect to curb the spread of COVID-19. In response, many biopharmaceutical companies are shifting how they work: Amarin withdrew part of its field force, while Amgen and Merck have instructed their sales teams to halt all in-person meetings with physicians and hospitals.

With a technology like VR, arguably even more so than in live settings, we can readily tap into multiple learning styles by integrating different types of media into a single experience.

2018 was filled with a number of significant developments for healthcare marketers. The rising demand to respect individual privacy rights dominated conversations surrounding digital marketing, as did the increasing importance of using data-driven email marketing tools to increase physician engagement and retention.

Behind every successful email marketing campaign stand fundamental building blocks to ensure reaching the right audiences. Top marketing execs dissect the anatomy of an effective campaign.

Decades ago, healthcare professionals along with the rest of the population were swamped with promotional direct mail. But in recent years, new technology like email, SMS, mobile applications, and AR/VR have diversified the ways in which healthcare marketers can reach physicians.